Generalized seizures after acute fluoxetine overdose in four adolescents.


Journal

The American journal of emergency medicine
ISSN: 1532-8171
Titre abrégé: Am J Emerg Med
Pays: United States
ID NLM: 8309942

Informations de publication

Date de publication:
01 2024
Historique:
received: 26 04 2023
revised: 06 09 2023
accepted: 08 10 2023
medline: 1 12 2023
pubmed: 14 11 2023
entrez: 13 11 2023
Statut: ppublish

Résumé

Fluoxetine is a selective serotonin reuptake inhibitor that is less frequently associated with severe toxicity in acute overdose compared with other psychotropic medications. Although rare, generalized seizure has been reported after isolated fluoxetine overdose. Most cases in the literature have occurred between one- and 16 h following acute ingestion of ≥1000 mg. Here, we present a series of four cases of adolescents who presented to our pediatric emergency department with reported or witnessed seizures after acute fluoxetine overdose between 3/2021 and 1/2022. These cases included intentional ingestions of fluoxetine at doses between 600 and 1200 mg (10-19.5 mg/kg), each of whom had a single, witnessed episode of generalized seizure activity which occurred between three- and nine-hours post-ingestion. All patients had signs of mild serotonin excess and two met conventional criteria for diagnosis of serotonin toxicity. All patients were evaluated by a medical toxicologist and were hospitalized for observation. No patient developed subsequent seizure or further complications related to overdose and no patient received neuroimaging, electroencephalography, or evaluation by a neurologist. Though previously described, seizure is an uncommon and potentially underappreciated complication after fluoxetine overdose and occurred in some of our patients at doses lower than those which have typically been reported in the literature.

Identifiants

pubmed: 37957092
pii: S0735-6757(23)00560-0
doi: 10.1016/j.ajem.2023.10.018
pii:
doi:

Substances chimiques

Fluoxetine 01K63SUP8D
Serotonin 333DO1RDJY
Selective Serotonin Reuptake Inhibitors 0

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

197.e5-197.e7

Informations de copyright

Copyright © 2023. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors have no conflicts of interest to disclose.

Auteurs

Matthew K Kolbeck (MK)

SUNY Upstate Medical University, Syracuse, NY, USA; Upstate New York Poison Center, Syracuse, NY, USA. Electronic address: kolbeckm@upstate.edu.

Rachel F Schult (RF)

Department of Emergency Medicine, University of Rochester Medical Center, Rochester, NY, USA; Upstate New York Poison Center, Syracuse, NY, USA.

Nicholas Nacca (N)

Department of Emergency Medicine, University of Rochester Medical Center, Rochester, NY, USA; Upstate New York Poison Center, Syracuse, NY, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH